-
Je něco špatně v tomto záznamu ?
Expression of CDK7/CAK in normal and tumor cells of diverse histogenesis, cell-cycle position and differentiation
J Bartkova, M Zemanova, J Bartek
Jazyk angličtina Země Spojené státy americké
Typ dokumentu srovnávací studie, práce podpořená grantem
Grantová podpora
IZ1919
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Wiley Online Library (archiv)
od 1996-01-01 do 2012-12-31
PubMed
8647641
Knihovny.cz E-zdroje
- MeSH
- buněčná diferenciace genetika účinky léků MeSH
- buněčné jádro metabolismus MeSH
- buněčný cyklus * genetika MeSH
- cyklin-dependentní kinasy * MeSH
- fibroblasty metabolismus MeSH
- genetická transkripce MeSH
- lidé MeSH
- lymfocyty metabolismus MeSH
- nádorové kmenové buňky * metabolismus MeSH
- nádorové proteiny * biosyntéza genetika MeSH
- nádory genetika metabolismus patologie MeSH
- protein-serin-threoninkinasy * biosyntéza genetika MeSH
- prsy cytologie metabolismus MeSH
- regulace genové exprese u nádorů MeSH
- regulace genové exprese * MeSH
- retina cytologie embryologie metabolismus MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
- srovnávací studie MeSH
The cyclin-dependent kinase 7 (CDK7) represents the 40-kDa catalytic subunit of the CDK-activating kinase, the enzyme responsible for activatory phosphorylation of multiple CDKs controlling G1, S and G2/M phases of the cell cycle. Here, we surveyed a wide range of normal and tumour cell types, in both cell culture and biopsy specimens, for abundance and subcellular localisation of the CDK7 protein. Immunoblotting and immunocytochemical analyses showed that CDK7 was (i) ubiquitously expressed in all cell types examined; (ii) exclusively nuclear; (iii) moderately elevated in tumour cells when compared with their normal cell counterparts; (iv) invariant throughout the cell cycle of normal lymphocytes, fibroblasts, breast epithelium and several cancer cell lines; and (v) clearly detectable even in quiescent cells, including highly differentiated cell types in situ. Our data are consistent with the emerging role for CDK7/CAK in multiple biological processes, possibly providing a link between cell-cycle control, transcriptional regulation and genomic integrity control.
Division for Cancer Biology Danish Cancer Society Copenhagen Denmark
Institute of hematology and Blood Transfusion Prague Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13017772
- 003
- CZ-PrNML
- 005
- 20130514090351.0
- 007
- ta
- 008
- 130509s1996 xxuad f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)8647641
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bártková, Jiřina $7 xx0094304 $u Division for Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.
- 245 10
- $a Expression of CDK7/CAK in normal and tumor cells of diverse histogenesis, cell-cycle position and differentiation / $c J Bartkova, M Zemanova, J Bartek
- 520 9_
- $a The cyclin-dependent kinase 7 (CDK7) represents the 40-kDa catalytic subunit of the CDK-activating kinase, the enzyme responsible for activatory phosphorylation of multiple CDKs controlling G1, S and G2/M phases of the cell cycle. Here, we surveyed a wide range of normal and tumour cell types, in both cell culture and biopsy specimens, for abundance and subcellular localisation of the CDK7 protein. Immunoblotting and immunocytochemical analyses showed that CDK7 was (i) ubiquitously expressed in all cell types examined; (ii) exclusively nuclear; (iii) moderately elevated in tumour cells when compared with their normal cell counterparts; (iv) invariant throughout the cell cycle of normal lymphocytes, fibroblasts, breast epithelium and several cancer cell lines; and (v) clearly detectable even in quiescent cells, including highly differentiated cell types in situ. Our data are consistent with the emerging role for CDK7/CAK in multiple biological processes, possibly providing a link between cell-cycle control, transcriptional regulation and genomic integrity control.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a prsy $x cytologie $x metabolismus $7 D001940
- 650 12
- $a buněčný cyklus $x genetika $7 D002453
- 650 02
- $a buněčná diferenciace $x genetika $x účinky léků $7 D002454
- 650 02
- $a buněčné jádro $x metabolismus $7 D002467
- 650 12
- $a cyklin-dependentní kinasy $7 D018844
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a fibroblasty $x metabolismus $7 D005347
- 650 12
- $a regulace genové exprese $7 D005786
- 650 02
- $a regulace genové exprese u nádorů $7 D015972
- 650 02
- $a lidé $7 D006801
- 650 02
- $a lymfocyty $x metabolismus $7 D008214
- 650 12
- $a nádorové proteiny $x biosyntéza $x genetika $7 D009363
- 650 02
- $a nádory $x genetika $x metabolismus $x patologie $7 D009369
- 650 12
- $a nádorové kmenové buňky $x metabolismus $7 D014411
- 650 12
- $a protein-serin-threoninkinasy $x biosyntéza $x genetika $7 D017346
- 650 02
- $a retina $x cytologie $x embryologie $x metabolismus $7 D012160
- 650 02
- $a genetická transkripce $7 D014158
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zemanová, Marie $u Institute of hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Bártek, Jiří, $d 1953- $7 xx0046271 $u Division for Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.
- 773 0_
- $t International Journal of Cancer $x 0020-7136 $g Roč. 66, č. 6 (1996), s. 732-737 $p Int J Cancer $w MED00002298
- 910 __
- $a ABA008 $b A 3679 $y 3 $z 0
- 990 __
- $a 20130509164730 $b ABA008
- 991 __
- $a 20130514090702 $b ABA008
- 999 __
- $a ok $b bmc $g 981120 $s 816105
- BAS __
- $a 3
- BMC __
- $x MED00002298 $i 0020-7136 $a 1996 $b 66 $c 6 $d 732-737 $m International journal of cancer $n Int J Cancer
- GRA __
- $a IZ1919 $p MZ0
- LZP __
- $a NLK 2013-05/lpbo